$CLSN The most important number to me is a market cap vs enterpise value. Gen I is just recognized as fast tract and can get an FDA approval likely. But, if it wotk for ovarian cancer, it could be adapted to other solid tumors as well. Covid vaccine-competitive. but if more easier handling or longer effect, then huge. Just two, minmum 1B MC values. Today MC is just 144M .